Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPTIMAL: Alteplase for High Microvascular Resistance in STEMI
NCT02894138Phase 3Unknown
- Sponsor
- Region Västra Götaland
- Start
- Sep 2016
- Primary completion
- Dec 2021
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of tissue-plasminogen activator in ST-segment elevation myocardial infarction (STEMI), sponsored by Region Västra Götaland. Status: unknown.
02
Drugs
tissue-plasminogen activator
03
Conditions
ST-segment elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT02894138.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02894138.